凯尼克萨制药 KNSA
$93.86 +$5.52 (+6.25%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $95.00 +1.21%
开盘$88.92
昨收$88.34
当日区间$88.41 – $94.48
成交量636.3K
市值$7.37B
市盈率（TTM）71.1
股息率–
基本面
最新报告季度：Q3, ended Sep 2026
营收$285.97M+58.1% YoY
营业利润$54.24M+125.8% YoY
净利润$47.35M+156.8% YoY
摊薄每股收益$0.56+143.5% YoY
自由现金流$47.37M+43.5% YoY
经营现金流$47.55M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率54.3%
营业利润率13.8%
净利率11.6%
净资产收益率17.6%
资产收益率12.9%
投入资本回报率17.3%
流动比率3.91
负债/资产比率27.8%
现金及投资$568.76M
总负债$3.92M
净现金（净负债）$564.84M
自由现金流/营收20.8%
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 报告营业总收入 | $285.97M | $243.60M | $214.27M | $677.56M | $202.13M |
| 营业总收入 | $285.97M | $243.60M | $214.27M | $677.56M | $202.13M |
| 营业成本 | $133.59M | $111.64M | $96.37M | $307.22M | $90.98M |
| 毛利润 | $152.38M | $131.96M | $117.89M | $370.35M | $111.15M |
| 营业费用 | $98.15M | $104.77M | $88.63M | $293.13M | $91.38M |
| 销售及管理费用 | $65.36M | $63.87M | $61.15M | $196.27M | $56.78M |
| 研发费用 | $32.79M | $40.90M | $27.48M | $96.85M | $34.61M |
| 营业利润 | $54.24M | $27.19M | $29.27M | $77.22M | $19.77M |
| 其他收入（支出） | $4.82M | $3.95M | $3.41M | $11.65M | $3.50M |
| 其他非经营性收入（支出） | $4.82M | $3.95M | $3.41M | $11.65M | $3.50M |
| 税前利润 | $59.06M | $31.15M | $32.68M | $88.87M | $23.27M |
| 税费 | $11.71M | $5.71M | $10.09M | $29.86M | $9.07M |
| 净利润 | $47.35M | $25.43M | $22.59M | $59.01M | $14.20M |
| 持续经营利润 | $47.35M | $25.43M | $22.59M | $59.01M | $14.20M |
| 归属母公司净利润 | $47.35M | $25.43M | $22.59M | $59.01M | $14.20M |
| 归属普通股股东净利润 | $47.35M | $25.43M | $22.59M | $59.01M | $14.20M |
| 基本每股收益 | $0.61 | $0.33 | $0.30 | $0.80 | $0.19 |
| 摊薄每股收益 | $0.56 | $0.30 | $0.27 | $0.75 | $0.17 |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $983.24M | $896.11M | $825.28M | $763.63M | $763.63M |
| 流动资产合计 | $750.10M | $668.63M | $594.17M | $527.18M | $527.18M |
| 现金及现金等价物与短期投资 | $568.76M | $525.93M | $468.09M | $414.07M | $414.07M |
| -现金及现金等价物 | $81.66M | $175.68M | $189.95M | $165.60M | $165.60M |
| -短期投资 | $487.10M | $350.25M | $278.14M | $248.48M | $248.48M |
| 应收款 | $30.78M | $23.49M | $23.22M | $15.59M | $15.59M |
| -应收账款 | $30.78M | $23.49M | $23.22M | $15.59M | $15.59M |
| 存货 | $108.03M | $70.93M | $73.14M | $54.90M | $54.90M |
| 其他流动资产 | $42.53M | $48.29M | $29.71M | $42.61M | $42.61M |
| 非流动资产合计 | $233.14M | $227.48M | $231.11M | $236.46M | $236.46M |
| 固定资产净值 | $9.85M | $10.93M | $11.32M | $11.75M | $11.75M |
| -固定资产原值 | $17.37M | $18.47M | $18.69M | $18.98M | $18.98M |
| -累计折旧 | -$7.52M | -$7.54M | -$7.37M | -$7.23M | -$7.23M |
| 商誉及其他无形资产 | $14.50M | $14.75M | $15.00M | $15.25M | $15.25M |
| -其他无形资产 | $14.50M | $14.75M | $15.00M | $15.25M | $15.25M |
| 一年以上递延资产 | $198.04M | $190.97M | $193.63M | $198.15M | $198.15M |
| 其他非流动资产 | $10.75M | $10.83M | $11.16M | $11.31M | $11.31M |
| 负债合计 | $273.05M | $241.96M | $219.59M | $196.03M | $196.03M |
| 流动负债合计 | $191.86M | $171.25M | $156.61M | $139.18M | $139.18M |
| 应付款 | $4.11M | $12.40M | $24.40M | $2.03M | $2.03M |
| -应付账款 | $4.11M | $12.40M | $24.40M | $2.03M | $2.03M |
| 一年内应计费用 | $136.93M | $114.49M | $94.08M | $90.60M | $90.60M |
| 短期债务及融资租赁负债 | $3.97M | $4.01M | $3.17M | $2.99M | $2.99M |
| -一年内到期融资租赁负债 | $3.97M | $4.01M | $3.17M | $2.99M | $2.99M |
| 其他流动负债 | $20.26M | $20.05M | $20.69M | $22.13M | $22.13M |
| 非流动负债合计 | $81.20M | $70.71M | $62.98M | $56.84M | $56.84M |
| 长期债务及融资租赁负债 | $3.92M | $4.89M | $5.86M | $6.51M | $6.51M |
| -长期融资租赁负债 | $3.92M | $4.89M | $5.86M | $6.51M | $6.51M |
| 一年以上递延负债 | $31.81M | $31.81M | $31.81M | $31.81M | $31.81M |
| 其他非流动负债 | $45.47M | $34.02M | $25.32M | $18.52M | $18.52M |
| 股东权益合计 | $710.19M | $654.15M | $605.69M | $567.61M | $567.61M |
| 股东权益 | $710.19M | $654.15M | $605.69M | $567.61M | $567.61M |
| 股本 | $21,000.00 | $21,000.00 | $21,000.00 | $21,000.00 | $21,000.00 |
| -普通股 | $21,000.00 | $21,000.00 | $21,000.00 | $21,000.00 | $21,000.00 |
| 资本公积 | $1.08B | $1.07B | $1.05B | $1.03B | $1.03B |
| 留存收益 | -$366.77M | -$414.11M | -$439.55M | -$462.14M | -$462.14M |
| 不影响留存收益的损益 | -$2.75M | -$1.38M | -$665,000.00 | -$25,000.00 | -$25,000.00 |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | $47.55M | $47.20M | $50.20M | $137.99M | $53.89M |
| 持续经营经营活动现金流净额 | $47.55M | $47.20M | $50.20M | $137.99M | $53.89M |
| 持续经营净利润 | $47.35M | $25.43M | $22.59M | $59.01M | $14.20M |
| 持续经营损益 | $8,000.00 | $22,000.00 | -$54,000.00 | -$120,000.00 | -$53,000.00 |
| 折旧、折耗与摊销 | $490,000.00 | $472,000.00 | $468,000.00 | $1.55M | $467,000.00 |
| 递延税款 | -$6.57M | $2.66M | $4.52M | $13.00M | $3.14M |
| 其他非现金项目 | $1.01M | $1.01M | $994,000.00 | $3.67M | $963,000.00 |
| 营运资金变动 | -$7.46M | $5.87M | $10.32M | $24.79M | $25.88M |
| -应收款变动 | -$7.29M | -$266,000.00 | -$7.63M | $26.13M | $36.15M |
| -存货变动 | -$37.10M | $2.21M | -$18.25M | -$28.53M | -$13.50M |
| -预付资产变动 | $5.75M | -$18.57M | $13.05M | -$22.48M | -$12.32M |
| -应付账款及应计费用变动 | $20.76M | $13.79M | $17.22M | $37.64M | $15.51M |
| -其他流动资产变动 | $20,000.00 | $249,000.00 | $125,000.00 | -$1.21M | -$3.04M |
| -其他流动负债变动 | $10.40M | $8.45M | $5.80M | $13.24M | $3.08M |
| 投资活动现金流净额 | -$138.56M | -$73.58M | -$31.92M | -$188.99M | -$70.81M |
| 持续经营投资活动现金流净额 | -$138.56M | -$73.58M | -$31.92M | -$188.99M | -$70.81M |
| 固定资产购置及出售净额 | -$180,000.00 | -$663,000.00 | -$161,000.00 | -$1.57M | -$633,000.00 |
| 投资购置及出售净额 | -$138.38M | -$72.92M | -$31.76M | -$187.43M | -$70.18M |
| 筹资活动现金流 | -$3.00M | $12.11M | $6.07M | $33.02M | $7.66M |
| 持续经营筹资活动现金流净额 | -$3.00M | $12.11M | $6.07M | $33.02M | $7.66M |
| 普通股发行净额 | -$9.08M | -$5.47M | -$316,000.00 | -$7.73M | -$918,000.00 |
| 股票期权行使所得 | $6.08M | $17.58M | $6.39M | $40.75M | $8.58M |
| 期末现金余额 | $81.66M | $175.68M | $189.95M | $165.60M | $165.60M |
| 现金净变动 | -$94.02M | -$14.28M | $24.36M | -$17.99M | -$9.26M |
| 期初现金余额 | $175.68M | $189.95M | $165.60M | $183.58M | $174.86M |
| 自由现金流 | $47.37M | $46.53M | $50.04M | $136.42M | $53.26M |
暂无评论——快来第一个聊聊 KNSA。